ASCPT 2016: A randomised double-blind dose escalation study to evaluate the safety and dose response of subcutaneous administration of coversin in healthy subjects
26 October 2017
Overview
A randomized double-blind dose escalation study to evaluate the safety and dose-response of subcutaneous administration of coversin in healthy subjects.
Download a copy of our scientific poster from ASCPT 2016 titled, 'A randomized double-blind dose escalation study of coversin'.